The Future of Psychedelic Medicine
Our Story
Find out what inspires us to support mental health disorders.
Our Mission
Supporting innovative therapies to help humans thrive.
Our Team
Multi-disciplinary collaboration
creating positive experiences and outcomes.
Mission
Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.
HAVN Labs
- HAVN Labs is building a psychedelic supply chain for clinical researchers. Through research, extraction, formulation and delivery of psychedelics, we aspire to define and standardize the future of modern medicine.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
350 Million
People globally are affected by a form of depression.
1 Trillion
Dollars lost annually in global workforce productivity due to depression and anxiety.
0
Formulas standardized across clinical studies of psychedelic compounds.
HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
Press Releases
HAVN LIFE SCIENCES Inc. Announces Cease Trade Order
Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life“), announces that on November 9, 2023, the ...
Read More →
Press Releases
HAVN LIFE SCIENCES Inc. Announces Filing of Annual Report by November 10, 2023
Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life“), reports that the Company’s external auditor has ...
Read More →
Press Releases
HAVN LIFE SCIENCES Inc. PROVIDES BI-WEEKLY MCTO STATUS UPDATE
Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life“), a biotechnology company pursuing standardized extraction of ...
Read More →